Stock Track | Oscar Health Plunges 8.35% as Barclays Maintains Sell Rating

Stock Track

Nov 10

Oscar Health, Inc. (OSCR) saw its stock plummet 8.35% in Sunday's trading session, following a bearish analyst report from Barclays. The significant drop comes after Barclays analyst Andrew Mok CFA reiterated a Sell rating on the health insurance company, maintaining a price target of $13.00.

The reaffirmation of the Sell rating by a major financial institution like Barclays appears to have sparked investor concern, leading to the sharp decline in Oscar Health's stock price. Analyst ratings and price targets often carry substantial weight in the market, influencing investor sentiment and trading decisions.

This development may signal ongoing challenges for Oscar Health in the competitive health insurance sector. Investors and market watchers will likely be closely monitoring the company's performance and any further analyst commentary in the coming days to gauge the potential long-term implications of this rating on Oscar Health's market position and stock valuation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1156517683"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156517683\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156517683?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 09:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156517683","market":"sg","top_or_hot":-1,"title":"Stock Track | Oscar Health Plunges 8.35% as Barclays Maintains Sell Rating","media":"Stock Track","content":"<p>Oscar Health, Inc. (OSCR) saw its stock plummet 8.35% in Sunday's trading session, following a bearish analyst report from Barclays. The significant drop comes after Barclays analyst Andrew Mok CFA reiterated a Sell rating on the health insurance company, maintaining a price target of $13.00.</p>\n\n<p>The reaffirmation of the Sell rating by a major financial institution like Barclays appears to have sparked investor concern, leading to the sharp decline in Oscar Health's stock price. Analyst ratings and price targets often carry substantial weight in the market, influencing investor sentiment and trading decisions.</p>\n\n<p>This development may signal ongoing challenges for Oscar Health in the competitive health insurance sector. Investors and market watchers will likely be closely monitoring the company's performance and any further analyst commentary in the coming days to gauge the potential long-term implications of this rating on Oscar Health's market position and stock valuation.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Oscar Health Plunges 8.35% as Barclays Maintains Sell Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Oscar Health Plunges 8.35% as Barclays Maintains Sell Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-10 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Oscar Health, Inc. (OSCR) saw its stock plummet 8.35% in Sunday's trading session, following a bearish analyst report from Barclays. The significant drop comes after Barclays analyst Andrew Mok CFA reiterated a Sell rating on the health insurance company, maintaining a price target of $13.00.</p>\n\n<p>The reaffirmation of the Sell rating by a major financial institution like Barclays appears to have sparked investor concern, leading to the sharp decline in Oscar Health's stock price. Analyst ratings and price targets often carry substantial weight in the market, influencing investor sentiment and trading decisions.</p>\n\n<p>This development may signal ongoing challenges for Oscar Health in the competitive health insurance sector. Investors and market watchers will likely be closely monitoring the company's performance and any further analyst commentary in the coming days to gauge the potential long-term implications of this rating on Oscar Health's market position and stock valuation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OSCR","symbol_name":"Oscar Health, Inc.","start_time":0,"source_url":"","article_id":"1156517683","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156517683","pubTimestamp":1762738950,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Oscar Health, Inc. (OSCR) saw its stock plummet 8.35% in Sunday's trading session, following a bearish analyst report from Barclays. The significant drop comes after Barclays analyst Andrew Mok CFA...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OSCR":"Oscar Health, Inc."},"translate_title":"个股追踪|奥斯卡健康暴跌8.35%巴克莱维持卖出评级","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSCR":1},"content_text":"Oscar Health, Inc. (OSCR) saw its stock plummet 8.35% in Sunday's trading session, following a bearish analyst report from Barclays. The significant drop comes after Barclays analyst Andrew Mok CFA reiterated a Sell rating on the health insurance company, maintaining a price target of $13.00.\nThe reaffirmation of the Sell rating by a major financial institution like Barclays appears to have sparked investor concern, leading to the sharp decline in Oscar Health's stock price. Analyst ratings and price targets often carry substantial weight in the market, influencing investor sentiment and trading decisions.\nThis development may signal ongoing challenges for Oscar Health in the competitive health insurance sector. Investors and market watchers will likely be closely monitoring the company's performance and any further analyst commentary in the coming days to gauge the potential long-term implications of this rating on Oscar Health's market position and stock valuation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}